Finance

Lists
603229:SHA
Zhejiang Ausun Pharmaceutical Co Ltd
CN¥7.80
-1.64%
(-0.13) 1D
Oct 14, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603229...
Open
CN¥7.87
High
CN¥7.91
Low
CN¥7.77
Mkt. cap
6.58B
Avg. vol.
7.31M
Volume
4.39M
Dividend
0.82%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jul 17, 2026
P/E ratio
79.01
52-wk high
CN¥10.81
52-wk low
CN¥7.15
EPS
CN¥0.10
Shares outstanding
160.00M
No. of employees
1K
Open
CN¥7.87
High
CN¥7.91
Low
CN¥7.77
Mkt. cap
6.58B
Avg. vol.
7.31M
Volume
4.39M
Dividend
0.82%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jul 17, 2026
P/E ratio
79.01
52-wk high
CN¥10.81
52-wk low
CN¥7.15
EPS
CN¥0.10
Shares outstanding
160.00M
No. of employees
1K
News stories
From web sources and news partners
About Zhejiang Ausun Pharmaceutical Co Ltd
CEO-
Employees1.33K
FoundedApr 22, 2010
Headquarters-
SectorPharmaceutical industry
Websiteausunpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
164.09M
146.80M
308.67M
158.94M
Cost of goods sold
74.64M
109.90M
116.10M
101.33M
Cost of revenue
74.64M
109.90M
116.10M
101.33M
Research and development expenses
25.28M
86.27M
30.76M
27.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.19M
43.63M
25.16M
27.55M
Operating expense
51.32M
122.51M
65.26M
64.56M
Total operating expenses
125.96M
232.42M
181.36M
165.89M
Operating income
38.13M
-85.62M
127.32M
-6.95M
Other non operating income
-4.56M
4.51M
-24.03M
23.70M
EBT including unusual items
38.67M
-95.44M
107.33M
22.96M
EBT excluding unusual items
38.79M
-91.98M
110.40M
-10.81M
Income tax expense
982.48K
-18.98M
10.67M
-214.34K
Effective tax rate
2.54%
19.89%
9.94%
-0.93%
Other operating expenses
1.65M
-1.11M
-1.44M
5.70M
Net income
37.69M
-76.46M
96.66M
23.18M
Net profit margin
22.97%
-52.09%
31.32%
14.58%
Earnings per share
-
-
-
-
Interest and investment income
11.95M
12.21M
9.94M
12.70M
Interest expense
-2.06M
-2.47M
-2.83M
-2.59M
Net interest expenses
9.89M
9.74M
7.12M
10.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
53.77M
-67.40M
145.53M
13.96M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps